Abdul Ezaz Mutlib

Abdul Ezaz Mutlib

Chief Executive Officer at FRONTAGE HOLDINGS CORPORATION

Net worth: 75 638 $ as of 2024-03-30

63 year
Health Technology
Consumer Services
Commercial Services

Profile

Abdul Ezaz Mutlib is currently the Chief Executive Officer at Frontage Laboratories, Inc. since 2010.
He is also the Chief Executive Officer at Frontage Holdings Corp.
since 2017.
Additionally, Dr. Mutlib has been a Member of the American Society For Mass Spectrometry since 1990.
In the past, he worked as the Director-Drug Metabolism at Pfizer Inc. from 2006 to 2010.
He also held positions as a Principal at Wyeth LLC, DuPont Merck Pharmaceutical Co., and Hoechst-Roussel Pharmaceuticals, Inc. Dr. Mutlib completed his undergraduate degree at The University of Sydney in 1987.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-25 411,098 ( 0.02% ) 75 638 $ 2024-03-30

Abdul Ezaz Mutlib active positions

CompaniesPositionStart
FRONTAGE HOLDINGS CORPORATION Chief Executive Officer 2023-01-02
Chief Executive Officer 2009-12-31
American Society For Mass Spectrometry Corporate Officer/Principal 1989-12-31
All active positions of Abdul Ezaz Mutlib

Former positions of Abdul Ezaz Mutlib

CompaniesPositionEnd
PFIZER, INC. Corporate Officer/Principal 2010-01-31
Hoechst-Roussel Pharmaceuticals, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Abdul Ezaz Mutlib's experience

Training of Abdul Ezaz Mutlib

The University of Sydney Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Abdul Ezaz Mutlib's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PFIZER, INC.

Health Technology

FRONTAGE HOLDINGS CORPORATION

Health Technology

Private companies5

Health Technology

Health Technology

Commercial Services

Hoechst-Roussel Pharmaceuticals, Inc.

American Society For Mass Spectrometry

See company connections
  1. Stock Market
  2. Insiders
  3. Abdul Ezaz Mutlib